MENU
BGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
BeiGene (BGNE) Ownership - Who owns BeiGene?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
c/o Mourant Governance Services (Cayman) Limited
Phone
+1 345 949-4123
Employees
10600
Web
https://www.beigene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.97B
P/E Ratio
N/A
Total Cash
2.7B
Projected Growth
N/A
Total Debt
1.1B
Revenue
3.32B
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash/Share
25.38
Total Debt/Equity
N/A
Revenue/Share
31.72 USD as % of share price
Fundamentals
BGNE
Capitalization
20B
P/E Ratio
N/A
Risk (Beta)
0.68
Dividend Yield
N/A
Total Cash
2.7B
Total Cash/Share
25.38
Total Debt
1.1B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
31.72%
Revenue
3.32B
ROE
N/A
Book Value
3.44B
P/B Ratio
5.46
Cash Flow
N/A
Earnings
-8.19
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
138K
Current Ratio
1.93
Current Revenue Per Employee
100159.90
Dividends Per Share - Security
N/A
EBITDA
-727.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
82.98
Revenue To Assets
-15.15
Shares Held By Institutions
21.4B
Shares Outstanding - Current
106M
Total Liabilities
2.4B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-0.721
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biopharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
c/o Mourant Governance Services (Cayman) Limited
Phone
+1 345 949-4123
Employees
10600
Web
https://www.beigene.com